Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Therapie
|
December 18, 2024
Methodological expectations for demonstration of health product effectiveness by observational studies
Michel Cucherat, Olivier Demarcq, Olivier Chassany, et al.
Therapie
|
November 13, 2024
Michel Cucherat, Olivier Demarcq, Olivier Chassany, et al.
Cancer Research
|
May 3, 2017
Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Patients
Emma Pailler, Marianne Oulhen, Isabelle Borget, et al.
Journal of Thoracic Disease
|
December 23, 2017
Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group
Hervé Le Caer, Isabelle Borget, Romain Corre, et al.
European Journal of Endocrinology
|
January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
Marie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
Endocrine-Related Cancer
|
February 14, 2013
Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy
Cecile N Chougnet, Sophie Leboulleux, Caroline Caramella, et al.
Bulletin Du Cancer
|
October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Oncology
|
March 9, 2007
Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial
Isabelle Borget, Anne Aupérin, Jean-Pierre Pignon, et al.
Endocrine-Related Cancer
|
August 30, 2022
Prognostic of recurrence and survival in poorly differentiated thyroid cancer
Segolene Hescot, Abir Al Ghuzlan, Theophraste Henry, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Therapie
|
December 18, 2024
Methodological expectations for demonstration of health product effectiveness by observational studies
Michel Cucherat, Olivier Demarcq, Olivier Chassany, et al.
Therapie
|
November 13, 2024
Michel Cucherat, Olivier Demarcq, Olivier Chassany, et al.
Cancer Research
|
May 3, 2017
Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non-Small Cell Lung Cancer Patients
Emma Pailler, Marianne Oulhen, Isabelle Borget, et al.
Journal of Thoracic Disease
|
December 23, 2017
Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group
Hervé Le Caer, Isabelle Borget, Romain Corre, et al.
European Journal of Endocrinology
|
January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network
Marie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
Endocrine-Related Cancer
|
February 14, 2013
Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy
Cecile N Chougnet, Sophie Leboulleux, Caroline Caramella, et al.
Bulletin Du Cancer
|
October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 19, 2019
F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients
Marie Terroir, Caroline Caramella, Isabelle Borget, et al.
Oncology
|
March 9, 2007
Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial
Isabelle Borget, Anne Aupérin, Jean-Pierre Pignon, et al.
Endocrine-Related Cancer
|
August 30, 2022
Prognostic of recurrence and survival in poorly differentiated thyroid cancer
Segolene Hescot, Abir Al Ghuzlan, Theophraste Henry, et al.
Page
of 14